JPMorgan Chase & Co. Acquires 225,238 Shares of Varex Imaging $VREX

JPMorgan Chase & Co. grew its stake in shares of Varex Imaging (NASDAQ:VREX) by 381.8% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 284,227 shares of the company’s stock after buying an additional 225,238 shares during the quarter. JPMorgan Chase & Co. owned 0.68% of Varex Imaging worth $3,524,000 at the end of the most recent quarter.

Several other large investors have also recently modified their holdings of VREX. Assenagon Asset Management S.A. grew its position in Varex Imaging by 166.4% during the 3rd quarter. Assenagon Asset Management S.A. now owns 296,128 shares of the company’s stock worth $3,672,000 after acquiring an additional 184,959 shares during the last quarter. Bailard Inc. bought a new stake in Varex Imaging in the third quarter valued at approximately $479,000. Rice Hall James & Associates LLC lifted its position in Varex Imaging by 20.8% in the third quarter. Rice Hall James & Associates LLC now owns 909,261 shares of the company’s stock valued at $11,275,000 after purchasing an additional 156,289 shares during the last quarter. SummerHaven Investment Management LLC purchased a new stake in shares of Varex Imaging during the third quarter valued at approximately $1,233,000. Finally, Neuberger Berman Group LLC grew its holdings in shares of Varex Imaging by 22.8% in the second quarter. Neuberger Berman Group LLC now owns 1,497,175 shares of the company’s stock worth $12,974,000 after purchasing an additional 277,870 shares during the last quarter.

Analysts Set New Price Targets

VREX has been the subject of several recent analyst reports. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Varex Imaging in a research note on Friday, March 27th. B. Riley Financial restated a “buy” rating on shares of Varex Imaging in a report on Thursday, February 12th. Wall Street Zen raised Varex Imaging from a “buy” rating to a “strong-buy” rating in a research report on Saturday, February 28th. Finally, Jefferies Financial Group reiterated a “hold” rating and issued a $14.50 price objective on shares of Varex Imaging in a report on Monday, February 2nd. Two research analysts have rated the stock with a Buy rating, one has given a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat.com, Varex Imaging has an average rating of “Hold” and a consensus target price of $16.17.

Insider Buying and Selling

In other Varex Imaging news, Director Jay K. Kunkel sold 4,510 shares of Varex Imaging stock in a transaction that occurred on Friday, March 20th. The shares were sold at an average price of $11.14, for a total value of $50,241.40. Following the completion of the sale, the director owned 23,450 shares of the company’s stock, valued at approximately $261,233. The trade was a 16.13% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Company insiders own 4.60% of the company’s stock.

Varex Imaging Price Performance

NASDAQ VREX opened at $10.50 on Friday. Varex Imaging has a one year low of $6.76 and a one year high of $14.56. The stock has a 50-day moving average of $12.48 and a 200 day moving average of $12.19. The company has a debt-to-equity ratio of 0.75, a quick ratio of 1.87 and a current ratio of 3.89. The company has a market capitalization of $439.95 million, a price-to-earnings ratio of -6.40 and a beta of 0.99.

Varex Imaging (NASDAQ:VREX) last announced its quarterly earnings results on Tuesday, February 10th. The company reported $0.19 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.14 by $0.05. Varex Imaging had a negative net margin of 7.92% and a positive return on equity of 8.43%. The firm had revenue of $209.60 million for the quarter, compared to the consensus estimate of $207.83 million. Varex Imaging has set its Q2 2026 guidance at 0.150-0.250 EPS. On average, sell-side analysts forecast that Varex Imaging will post 0.53 EPS for the current year.

Varex Imaging Company Profile

Varex Imaging Corporation is a global provider of X-ray imaging components and solutions for the medical, security and industrial markets. The company designs, develops and manufactures a broad range of products that convert X-ray energy into high-resolution digital images. Its portfolio includes X-ray tubes, flat panel detectors, digital sensors, specialty radiographic tubes and related software, all engineered to meet the demanding requirements of original equipment manufacturers (OEMs) in diagnostic imaging, computed tomography (CT), fluoroscopy, mammography, dental radiography and non-destructive testing applications.

The company’s medical imaging offerings support a wide spectrum of clinical modalities, from portable radiography systems to advanced CT scanners, enhancing image quality and dose efficiency for healthcare providers.